Angiogenesis
During the past decade there has been considerable research in understanding
the mechanism of angiogenesis is the formation of new blood vessels.
This process is crucial for normal growth and development. In healthy
adults, angiogensis does not normally occur except during ovulation,
in the placenta and for wound healing.
Cartilage:
a proven source of angiogenesis inhibitors
Cartilage is an avascular tissue highly resistant to invasion by
blood vessels when compared to other tissues. The avascular property
of cartilage has prompted several laboratories to study the biological
potential of this tissue to inhibit blood vessel formation.
Our liquid extract of shark cartilage contains
higher concentrations of active elements. shark Cartilage has been
available for several years in powdered, caplet or capsule form.
All these formulations forces the user to ingest large quantities
of the product. CarTCell is unique because of its patented manufacturing
process which allows the extraction of selected molecules.
Consider the advances of CarTCell:
- A proven source of angiogenic
inhibitors
- High concentration of selected
molecules
- Easy to use and absorb
- Superior quality control
More
About CarTCell from Atrium
More About Angiogenic
Balance
Angiogenesis, the formation of new blood vessels,
is a natural and normal physiological phenomenon that occurs in
the human body. In a healthy body, angiogenesis and the inhibition
of angiogenesis exist together in a well-balanced homeostasis. This
delicate Angiogenic Balance fulfills the needs for blood vessel
formation in response to physiological demands while preventing
uncontrolled pathological angiogenesis. When our bodies experience
sun exposure, stress, aging and angiogenesis related conditions
such as tumor growth, arthritis and psoriasis, the Angiogenic Balance
tends to favor angiogenesis or the unregulated formation of new
blood vessels. The healthy objective is then to reestablish the
normal equilibrium through the use of products with proven antiangiogenic
activity. Dietary supplementation with a proven angiogenesis inhibitor
such as frozen liquid cartilage extract can support each individual's
balanced angiogenic state.
Assessing Your Needs
The current research does not provide any diagnostic measurements
of human angiogenic activity. Dosage could be made simpler if there
was a method to analyze angiogenic balance in each individual, much
like a blood test or urine analysis but no reliable marker exists
at this time. It is then suggested by health professionals to determine
your need in antiangiogenic activity by considering two main factors:
body weight and the severity of the condition.
Indeed, dosage to achieve angiogenic balance can
depend upon your age, genetics and family history. If close relatives
have experienced angiogenic dependent conditions a Maintenance Dose
is ideal for a healthy balance. Body weight and your current health
status are the primary factors that influence your choice of protocol.
A heavier person needs a greater dose than the average (75 k). Those
with severe conditions would benefit from a protocol using higher
dosage (as shown in the table below).
In addition, the knowledge and experience of your
health care practitioner can help decide which protocol is best
for you. The following table is helpful to determine your daily
intake of frozen liquid cartilage extract ( CarTCell ).

Spreading The CarTCell Dosage
It is recommended to spread the dosage throughout the day.
When a daily intake of 3 or 6 bottles, it is preferable to divide
the number of bottles in three different periods through the day
(1-1-1 or 2-2-2 in the morning, noon and evening).
Quantity -
24 vials - Frozen
Each vial is one dose.
The Following Articles about CarTCell are in Adobe PDF Format
To view these files you'll need the Adobe Acrobat Reader installed.
If you do not have it, you can get it FREE by clicking HERE
What
Is Angiogenesis?
Psoriasis:
An Integrated Natural Approach
By Dr. Thomas Bayne, DC.
Beauty
from "Without and Within"
By Stephen Holt M.D.
Nutriceutic
als and Angiogenesis- New Therapeutic Horizons
By Stephen Holt M.D
Cartilage
and Nutriceutical Update
By Stephen Holt M.D.
Manufacturing
Process for CarTCell
CarTCell
®
is a cartilage liquid extract
with Scientifically Proven Oral Bioavailability
In 1999, a clinical human study
of CarTCell was published in the peer reviewed Journal of
Surgical Research (volume 87, pp. 108–113). The double-blind
study (which included a placebo) showed that CarTCell could
be assimilated via the oral route. It is the first time that
such bioavailability has been demonstrated for a cartilage
extract in a rigorous scientific study.
Atrium uses the most advanced
cellular and molecular biology technologies to manufacture
CarTCell and CarTCell NF (non frozen). We use an exclusive
and patented hypotonic shock cell extraction process to break
the cell membrane and extract molecules at low temperatures
to preserve the integrity of the molecules and to obtain maximum
activity in each bottle. The molecules are separated based
on their molecular weights, concentrated, and marketed in
a liquid form that can be taken orally.
Unlike other manufacturers,
Atrium uses only those molecules that produce the desired
effect. That explains why a large number of health professionals
around the world now prefer offering their patients CarTCell®. |
|